Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup

Although drugable fibroblast growth factor receptor (FGFR) alterations in squamous cell carcinomas (SCC) of various entities are well known, little is known about FGFR modifications in squamous differentiated bladder cancer. Therefore, our study evaluated FGFR1-3 alterations as a putative therapeuti...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Baldia, Philipp H., Maurer, Angela, Heide, Timon, Rose, Michael, Stoehr, Robert, Hartmann, Arndt, Williams, Sarah V., Knowles, Margaret A., Knuechel, Ruth, Gaisa, Nadine T.
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342089/
https://ncbi.nlm.nih.gov/pubmed/27669755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12198
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky